Explore the words cloud of the NSC-Reconstruct project. It provides you a very rough idea of what is the project "NSC-Reconstruct" about.
The following table provides information about the project.
UNIVERSITA DEGLI STUDI DI MILANO
|Coordinator Country||Italy [IT]|
|Total cost||8˙169˙231 €|
|EC max contribution||8˙168˙495 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2020-01-01 to 2023-12-31|
Take a look of project's partnership.
|1||UNIVERSITA DEGLI STUDI DI MILANO||IT (MILANO)||coordinator||1˙518˙495.00|
|2||LUNDS UNIVERSITET||SE (LUND)||participant||930˙000.00|
|3||UNIVERSITA DEGLI STUDI DI TORINO||IT (TORINO)||participant||780˙000.00|
|4||KAROLINSKA INSTITUTET||SE (STOCKHOLM)||participant||680˙000.00|
|5||THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE||UK (CAMBRIDGE)||participant||680˙000.00|
|6||UNIVERSITATSKLINIKUM BONN||DE (BONN)||participant||680˙000.00|
|7||CARDIFF UNIVERSITY||UK (CARDIFF)||participant||500˙000.00|
|8||HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH||DE (NEUHERBERG)||participant||500˙000.00|
|9||VIB||BE (ZWIJNAARDE - GENT)||participant||500˙000.00|
|10||KOBENHAVNS UNIVERSITET||DK (KOBENHAVN)||participant||400˙000.00|
|11||MILTENYI BIOTEC GMBH||DE (BERGISH GLADBACH)||participant||400˙000.00|
|12||LIFE AND BRAIN GMBH||DE (BONN)||participant||300˙000.00|
|13||NOVO NORDISK A/S||DK (BAGSVAERD)||participant||300˙000.00|
Neurodegenerative diseases and brain injuries affect large patient groups and carry large unmet clinical needs. NSC-Reconstruct will respond to these needs by developing innovative therapies based on cell replacement, cell reprogramming and circuit reconstruction that have the potential to transform how we treat a wide range of neurological diseases and disorders. In this area of clinical science European research has generated groundbreaking knowledge that has resulted in a pioneering human embryonic stem cell-derived product that is now entering clinical trials for Parkinson’s Disease (PD). In NSC-Reconstruct we will move beyond the replacement of a single neuronal type towards future cell therapies with enhanced authenticity, functions and compositions. NSC-Reconstruct will address PD as an example of disorder for which single neuron replacement has been developed. Our focus in PD will be on incorporating improved cell types and on local network reconstruction. We will also work on repairing long distance networks such as those affected in Huntington’s disease and finally in restoring the complex networks and projections of the cerebral cortex to achieve effective repair in conditions known to affect this structure, such as trauma or stroke. NSC-Reconstruct will lead to (i) the generation of neuronal types with clinically relevant functionality starting from human pluripotent stem cells or through in situ reprogramming, (ii) the optimization of donor cell composition through grafting of functional modules comprising distinct cell types capable of forming appropriate connections, (iii) the restoration of function through the reconstruction of these damaged connections and finally (iv) a greater understanding of the immunogenicity of grafted cells and how this can be minimized. Ultimately, NSC-Reconstruct will provide unique knowledge and products that will pave the way for future CNS cell replacement therapies using functionally enhanced and immune-tolerant cells.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NSC-RECONSTRUCT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "NSC-RECONSTRUCT" are provided by the European Opendata Portal: CORDIS opendata.
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone MetastasisRead More
Collaboration for innovation: Establishment of a pan-nematode drug development platformRead More
Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan AfricaRead More